1 Sexual Dysfunction Drugs Market Overview 1.1 Product Overview and Scope of Sexual Dysfunction Drugs 1.2 Sexual Dysfunction Drugs Segment by Type 1.2.1 Global Sexual Dysfunction Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Oral Therapy 1.2.3 Intracavernosal Therapy 1.2.4 Hormonal Therapy 1.2.5 Transurethral Therapy 1.3 Sexual Dysfunction Drugs Segment by User 1.3.1 Global Sexual Dysfunction Drugs Sales Comparison by User: (2022-2028) 1.3.2 Male 1.3.3 Female 1.4 Global Sexual Dysfunction Drugs Market Size Estimates and Forecasts 1.4.1 Global Sexual Dysfunction Drugs Revenue 2017-2028 1.4.2 Global Sexual Dysfunction Drugs Sales 2017-2028 1.4.3 Sexual Dysfunction Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Sexual Dysfunction Drugs Market Competition by Manufacturers 2.1 Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Sexual Dysfunction Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Sexual Dysfunction Drugs Manufacturing Sites, Area Served, Product Type 2.5 Sexual Dysfunction Drugs Market Competitive Situation and Trends 2.5.1 Sexual Dysfunction Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Sexual Dysfunction Drugs Players Market Share by Revenue 2.5.3 Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Sexual Dysfunction Drugs Retrospective Market Scenario by Region 3.1 Global Sexual Dysfunction Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Sexual Dysfunction Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Sexual Dysfunction Drugs Market Facts & Figures by Country 3.3.1 North America Sexual Dysfunction Drugs Sales by Country 3.3.2 North America Sexual Dysfunction Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Sexual Dysfunction Drugs Market Facts & Figures by Country 3.4.1 Europe Sexual Dysfunction Drugs Sales by Country 3.4.2 Europe Sexual Dysfunction Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Sexual Dysfunction Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Sexual Dysfunction Drugs Sales by Region 3.5.2 Asia Pacific Sexual Dysfunction Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Sexual Dysfunction Drugs Market Facts & Figures by Country 3.6.1 Latin America Sexual Dysfunction Drugs Sales by Country 3.6.2 Latin America Sexual Dysfunction Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Sexual Dysfunction Drugs Sales by Country 3.7.2 Middle East and Africa Sexual Dysfunction Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Sexual Dysfunction Drugs Historic Market Analysis by Type 4.1 Global Sexual Dysfunction Drugs Sales Market Share by Type (2017-2022) 4.2 Global Sexual Dysfunction Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Sexual Dysfunction Drugs Price by Type (2017-2022) 5 Global Sexual Dysfunction Drugs Historic Market Analysis by User 5.1 Global Sexual Dysfunction Drugs Sales Market Share by User (2017-2022) 5.2 Global Sexual Dysfunction Drugs Revenue Market Share by User (2017-2022) 5.3 Global Sexual Dysfunction Drugs Price by User (2017-2022) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Pfizer Sexual Dysfunction Drugs Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 GlaxoSmithKline 6.2.1 GlaxoSmithKline Corporation Information 6.2.2 GlaxoSmithKline Description and Business Overview 6.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Product Portfolio 6.2.5 GlaxoSmithKline Recent Developments/Updates 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description and Business Overview 6.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Merck Sexual Dysfunction Drugs Product Portfolio 6.3.5 Merck Recent Developments/Updates 6.4 Eli Lilly 6.4.1 Eli Lilly Corporation Information 6.4.2 Eli Lilly Description and Business Overview 6.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Eli Lilly Sexual Dysfunction Drugs Product Portfolio 6.4.5 Eli Lilly Recent Developments/Updates 6.5 AbbVie 6.5.1 AbbVie Corporation Information 6.5.2 AbbVie Description and Business Overview 6.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 AbbVie Sexual Dysfunction Drugs Product Portfolio 6.5.5 AbbVie Recent Developments/Updates 6.6 Bayer 6.6.1 Bayer Corporation Information 6.6.2 Bayer Description and Business Overview 6.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Bayer Sexual Dysfunction Drugs Product Portfolio 6.6.5 Bayer Recent Developments/Updates 6.7 Teva Pharmaceutical Industries 6.6.1 Teva Pharmaceutical Industries Corporation Information 6.6.2 Teva Pharmaceutical Industries Description and Business Overview 6.6.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Portfolio 6.7.5 Teva Pharmaceutical Industries Recent Developments/Updates 6.8 Takeda 6.8.1 Takeda Corporation Information 6.8.2 Takeda Description and Business Overview 6.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Takeda Sexual Dysfunction Drugs Product Portfolio 6.8.5 Takeda Recent Developments/Updates 6.9 Apricus Biosciences 6.9.1 Apricus Biosciences Corporation Information 6.9.2 Apricus Biosciences Description and Business Overview 6.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Apricus Biosciences Sexual Dysfunction Drugs Product Portfolio 6.9.5 Apricus Biosciences Recent Developments/Updates 6.10 Emotional Brain 6.10.1 Emotional Brain Corporation Information 6.10.2 Emotional Brain Description and Business Overview 6.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Emotional Brain Sexual Dysfunction Drugs Product Portfolio 6.10.5 Emotional Brain Recent Developments/Updates 6.11 Ivix LLX 6.11.1 Ivix LLX Corporation Information 6.11.2 Ivix LLX Sexual Dysfunction Drugs Description and Business Overview 6.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Ivix LLX Sexual Dysfunction Drugs Product Portfolio 6.11.5 Ivix LLX Recent Developments/Updates 6.12 Leadiant Biosciences 6.12.1 Leadiant Biosciences Corporation Information 6.12.2 Leadiant Biosciences Sexual Dysfunction Drugs Description and Business Overview 6.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Product Portfolio 6.12.5 Leadiant Biosciences Recent Developments/Updates 6.13 NexMed 6.13.1 NexMed Corporation Information 6.13.2 NexMed Sexual Dysfunction Drugs Description and Business Overview 6.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.13.4 NexMed Sexual Dysfunction Drugs Product Portfolio 6.13.5 NexMed Recent Developments/Updates 6.14 S1 Biopharma 6.14.1 S1 Biopharma Corporation Information 6.14.2 S1 Biopharma Sexual Dysfunction Drugs Description and Business Overview 6.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.14.4 S1 Biopharma Sexual Dysfunction Drugs Product Portfolio 6.14.5 S1 Biopharma Recent Developments/Updates 6.15 Vietstar Biomedical Research 6.15.1 Vietstar Biomedical Research Corporation Information 6.15.2 Vietstar Biomedical Research Sexual Dysfunction Drugs Description and Business Overview 6.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022) 6.15.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Product Portfolio 6.15.5 Vietstar Biomedical Research Recent Developments/Updates 7 Sexual Dysfunction Drugs Manufacturing Cost Analysis 7.1 Sexual Dysfunction Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Sexual Dysfunction Drugs 7.4 Sexual Dysfunction Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Sexual Dysfunction Drugs Distributors List 8.3 Sexual Dysfunction Drugs Customers 9 Sexual Dysfunction Drugs Market Dynamics 9.1 Sexual Dysfunction Drugs Industry Trends 9.2 Sexual Dysfunction Drugs Market Drivers 9.3 Sexual Dysfunction Drugs Market Challenges 9.4 Sexual Dysfunction Drugs Market Restraints 10 Global Market Forecast 10.1 Sexual Dysfunction Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Sexual Dysfunction Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by Type (2023-2028) 10.2 Sexual Dysfunction Drugs Market Estimates and Projections by User 10.2.1 Global Forecasted Sales of Sexual Dysfunction Drugs by User (2023-2028) 10.2.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by User (2023-2028) 10.3 Sexual Dysfunction Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Sexual Dysfunction Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Sexual Dysfunction Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Sexual Dysfunction Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million) Table 2. Global Sexual Dysfunction Drugs Sales Growth Rate Comparison by User (2022-2028) & (K Pcs) & (US$ Million) Table 3. Global Sexual Dysfunction Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Sexual Dysfunction Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Sexual Dysfunction Drugs Sales (K Pcs) of Key Manufacturers (2017-2022) Table 6. Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Sexual Dysfunction Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Sexual Dysfunction Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Sexual Dysfunction Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022) Table 10. Manufacturers Sexual Dysfunction Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Sexual Dysfunction Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Sexual Dysfunction Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexual Dysfunction Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Sexual Dysfunction Drugs Sales by Region (2017-2022) & (K Pcs) Table 16. Global Sexual Dysfunction Drugs Sales Market Share by Region (2017-2022) Table 17. Global Sexual Dysfunction Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Sexual Dysfunction Drugs Sales by Country (2017-2022) & (K Pcs) Table 20. North America Sexual Dysfunction Drugs Sales Market Share by Country (2017-2022) Table 21. North America Sexual Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Sexual Dysfunction Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Sexual Dysfunction Drugs Sales by Country (2017-2022) & (K Pcs) Table 24. Europe Sexual Dysfunction Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Sexual Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Sexual Dysfunction Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Sexual Dysfunction Drugs Sales by Region (2017-2022) & (K Pcs) Table 28. Asia Pacific Sexual Dysfunction Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Sexual Dysfunction Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Sexual Dysfunction Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Sexual Dysfunction Drugs Sales by Country (2017-2022) & (K Pcs) Table 32. Latin America Sexual Dysfunction Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Sexual Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Sexual Dysfunction Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2017-2022) & (K Pcs) Table 36. Middle East and Africa Sexual Dysfunction Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Sexual Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Sexual Dysfunction Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Sexual Dysfunction Drugs Sales by Type (2017-2022) & (K Pcs) Table 40. Global Sexual Dysfunction Drugs Sales Market Share by Type (2017-2022) Table 41. Global Sexual Dysfunction Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Sexual Dysfunction Drugs Revenue Share by Type (2017-2022) Table 43. Global Sexual Dysfunction Drugs Price by Type (2017-2022) & (USD/Pcs) Table 44. Global Sexual Dysfunction Drugs Sales (K Pcs) by User (2017-2022) Table 45. Global Sexual Dysfunction Drugs Sales Market Share by User (2017-2022) Table 46. Global Sexual Dysfunction Drugs Revenue by User (2017-2022) & (US$ Million) Table 47. Global Sexual Dysfunction Drugs Revenue Share by User (2017-2022) Table 48. Global Sexual Dysfunction Drugs Price by User (2017-2022) & (USD/Pcs) Table 49. Pfizer Corporation Information Table 50. Pfizer Description and Business Overview Table 51. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 52. Pfizer Sexual Dysfunction Drugs Product Table 53. Pfizer Recent Developments/Updates Table 54. GlaxoSmithKline Corporation Information Table 55. GlaxoSmithKline Description and Business Overview Table 56. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 57. GlaxoSmithKline Sexual Dysfunction Drugs Product Table 58. GlaxoSmithKline Recent Developments/Updates Table 59. Merck Corporation Information Table 60. Merck Description and Business Overview Table 61. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 62. Merck Sexual Dysfunction Drugs Product Table 63. Merck Recent Developments/Updates Table 64. Eli Lilly Corporation Information Table 65. Eli Lilly Description and Business Overview Table 66. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 67. Eli Lilly Sexual Dysfunction Drugs Product Table 68. Eli Lilly Recent Developments/Updates Table 69. AbbVie Corporation Information Table 70. AbbVie Description and Business Overview Table 71. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 72. AbbVie Sexual Dysfunction Drugs Product Table 73. AbbVie Recent Developments/Updates Table 74. Bayer Corporation Information Table 75. Bayer Description and Business Overview Table 76. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 77. Bayer Sexual Dysfunction Drugs Product Table 78. Bayer Recent Developments/Updates Table 79. Teva Pharmaceutical Industries Corporation Information Table 80. Teva Pharmaceutical Industries Description and Business Overview Table 81. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 82. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Table 83. Teva Pharmaceutical Industries Recent Developments/Updates Table 84. Takeda Corporation Information Table 85. Takeda Description and Business Overview Table 86. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 87. Takeda Sexual Dysfunction Drugs Product Table 88. Takeda Recent Developments/Updates Table 89. Apricus Biosciences Corporation Information Table 90. Apricus Biosciences Description and Business Overview Table 91. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 92. Apricus Biosciences Sexual Dysfunction Drugs Product Table 93. Apricus Biosciences Recent Developments/Updates Table 94. Emotional Brain Corporation Information Table 95. Emotional Brain Description and Business Overview Table 96. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 97. Emotional Brain Sexual Dysfunction Drugs Product Table 98. Emotional Brain Recent Developments/Updates Table 99. Ivix LLX Corporation Information Table 100. Ivix LLX Description and Business Overview Table 101. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 102. Ivix LLX Sexual Dysfunction Drugs Product Table 103. Ivix LLX Recent Developments/Updates Table 104. Leadiant Biosciences Corporation Information Table 105. Leadiant Biosciences Description and Business Overview Table 106. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 107. Leadiant Biosciences Sexual Dysfunction Drugs Product Table 108. Leadiant Biosciences Recent Developments/Updates Table 109. NexMed Corporation Information Table 110. NexMed Description and Business Overview Table 111. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 112. NexMed Sexual Dysfunction Drugs Product Table 113. NexMed Recent Developments/Updates Table 114. S1 Biopharma Corporation Information Table 115. S1 Biopharma Description and Business Overview Table 116. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 117. S1 Biopharma Sexual Dysfunction Drugs Product Table 118. S1 Biopharma Recent Developments/Updates Table 119. Vietstar Biomedical Research Corporation Information Table 120. Vietstar Biomedical Research Description and Business Overview Table 121. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 122. Vietstar Biomedical Research Sexual Dysfunction Drugs Product Table 123. Vietstar Biomedical Research Recent Developments/Updates Table 124. Production Base and Market Concentration Rate of Raw Material Table 125. Key Suppliers of Raw Materials Table 126. Sexual Dysfunction Drugs Distributors List Table 127. Sexual Dysfunction Drugs Customers List Table 128. Sexual Dysfunction Drugs Market Trends Table 129. Sexual Dysfunction Drugs Market Drivers Table 130. Sexual Dysfunction Drugs Market Challenges Table 131. Sexual Dysfunction Drugs Market Restraints Table 132. Global Sexual Dysfunction Drugs Sales Forecast by Type (2023-2028) & (K Pcs) Table 133. Global Sexual Dysfunction Drugs Sales Market Share Forecast by Type (2023-2028) Table 134. Global Sexual Dysfunction Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 135. Global Sexual Dysfunction Drugs Revenue Market Share Forecast by Type (2023-2028) Table 136. Global Sexual Dysfunction Drugs Sales Forecast by User (2023-2028) & (K Pcs) Table 137. Global Sexual Dysfunction Drugs Sales Market Share Forecast by User (2023-2028) Table 138. Global Sexual Dysfunction Drugs Revenue Forecast by User (2023-2028) & (US$ Million) Table 139. Global Sexual Dysfunction Drugs Revenue Market Share Forecast by User (2023-2028) Table 140. Global Sexual Dysfunction Drugs Sales Forecast by Region (2023-2028) & (K Pcs) Table 141. Global Sexual Dysfunction Drugs Sales Market Share Forecast by Region (2023-2028) Table 142. Global Sexual Dysfunction Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 143. Global Sexual Dysfunction Drugs Revenue Market Share Forecast by Region (2023-2028) Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Sexual Dysfunction Drugs Figure 2. Global Sexual Dysfunction Drugs Market Share by Type in 2021 & 2028 Figure 3. Oral Therapy Product Picture Figure 4. Intracavernosal Therapy Product Picture Figure 5. Hormonal Therapy Product Picture Figure 6. Transurethral Therapy Product Picture Figure 7. Global Sexual Dysfunction Drugs Market Share by User in 2021 & 2028 Figure 8. Male Figure 9. Female Figure 10. Global Sexual Dysfunction Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Sexual Dysfunction Drugs Market Size (2017-2028) & (US$ Million) Figure 12. Global Sexual Dysfunction Drugs Sales (2017-2028) & (K Pcs) Figure 13. Sexual Dysfunction Drugs Sales Share by Manufacturers in 2021 Figure 14. Global Sexual Dysfunction Drugs Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Sexual Dysfunction Drugs Players: Market Share by Revenue in 2021 Figure 16. Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Sexual Dysfunction Drugs Sales Market Share by Region (2017-2022) Figure 18. Global Sexual Dysfunction Drugs Sales Market Share by Region in 2021 Figure 19. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2017-2022) Figure 20. Global Sexual Dysfunction Drugs Revenue Market Share by Region in 2021 Figure 21. U.S. Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. China Taiwan Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Mexico Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Brazil Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Argentina Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Turkey Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Saudi Arabia Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. UAE Sexual Dysfunction Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Sales Market Share of Sexual Dysfunction Drugs by Type (2017-2022) Figure 44. Manufacturing Cost Structure of Sexual Dysfunction Drugs Figure 45. Manufacturing Process Analysis of Sexual Dysfunction Drugs Figure 46. Sexual Dysfunction Drugs Industrial Chain Analysis Figure 47. Channels of Distribution Figure 48. Distributors Profiles Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

Pfizer GlaxoSmithKline Merck Eli Lilly AbbVie Bayer Teva Pharmaceutical Industries Takeda Apricus Biosciences Emotional Brain Ivix LLX Leadiant Biosciences NexMed S1 Biopharma Vietstar Biomedical Research